Latest News

Filters close
Released: 6-Sep-2022 4:45 PM EDT
El Cancer Research Institute Presentará La Segunda Conferencia Virtual en Español Cri De Inmunoterapia Para Pacientes Con Cáncer, Moderada Por Ana Patricia Gámez, Quien Compartirá Información Vital Para La Comunidad Hispana, Pacientes Y Sus Familias
Cancer Research Institute

El Cancer Research Institute (CRI), una organización sin fines de lucro consagrada a aprovechar la capacidad del sistema inmunitario para combatir y potencialmente curar todos los tipos de cáncer, ofrecerá su segunda Conferencia Virtual CRI de Inmunoterapia para Pacientes con Cáncer, el 22 de septiembre de 2022, de 2 a 5 p. m. (hora del este).

Comment
Released: 6-Sep-2022 4:45 PM EDT
Cancer Research Institute to Host Second-Annual Spanish-Language Virtual Immunotherapy Patient Summit, Moderated by Ana Patricia Gámez, to Connect the U.S. Hispanic Cancer Community with Information That Can Save Lives
 Cancer Research Institute

The Cancer Research Institute (CRI), a nonprofit organization spearheading transformative research to harness the immune system’s power to control and potentially cure all cancers, will offer its second annual CRI Virtual Immunotherapy Patient Summit in Spanish on September 22, 2022, 2-5 p.m. ET.

Comment
Released: 22-Jun-2022 1:20 PM EDT
Cancer Research Institute Names Newest Class of Lloyd J. Old STARs, Today’s Visionaries in Cancer Immunotherapy Research
 Cancer Research Institute

Six U.S. scientists have been awarded $1.25 million each over 5 years to conduct high-risk, high-reward cancer immunology research with the potential to transform cancer treatment

Comment
Released: 1-Jun-2022 10:05 AM EDT
Cellular Cancer Immunotherapy Clinical Development Continues to Evolve and Expand with Novel Technologies and Targets, New Report From Cancer Research Institute Shows
 Cancer Research Institute

Latest analysis from the Cancer Research Institute of the global landscape of cellular immunotherapies, including R&D trends and real-world usage, highlights key challenges including effective solid tumor targeting, manufacturing complexities, and commercial access to approved therapies

Comment
Released: 27-May-2022 2:35 PM EDT
Cancer Research Institute Hosts 10th Annual Cancer Immunotherapy Month™ Celebrating Lifesaving Discovery in Immuno-Oncology
 Cancer Research Institute

Global celebration of 10 years of discovery and lifesaving innovation in immuno-oncology

Comment
Released: 11-May-2022 8:00 AM EDT
First Patients Dosed in Phase 2 Platform Clinical Trial Testing Novel Immunotherapy Combinations in Highly Malignant Ovarian Cancer
 Cancer Research Institute (CRI) and Ovarian Cancer Research Alliance (OCRA)

A phase 2 clinical trial testing novel immunotherapy combinations in aggressive ovarian cancer has opened and first patients have begun treatment.

Comment
Newswise: Cancer Immunotherapy Clinical Trials Continue to Grow Globally, Combination Approaches Outpace Monotherapy Trials
Released: 10-Feb-2022 9:10 AM EST
Cancer Immunotherapy Clinical Trials Continue to Grow Globally, Combination Approaches Outpace Monotherapy Trials
 Cancer Research Institute

A new report from the Cancer Research Institute on the global landscape of PD1/PDL1 immunotherapy clinical development

Comment
Released: 4-Nov-2021 8:00 AM EDT
Cancer Research Institute to Honor Developers of COVID-19 mRNA Vaccines in Historic Gathering: “This Technology Will Play a Big Role in Cancer Treatment”
 Cancer Research Institute

CRI will bestow the 2021 William B. Coley Award for Distinguished Research in Basic Immunology on four mRNA vaccine scientists followed by roundtable on origin and future application to cancer treatment.

Comment
Released: 1-Oct-2021 8:35 AM EDT
CRI Immunotherapy Summit Grows Along with Cancer Treatment Prospects - Virtual Gathering of Patients, Experts Hosted by Tamron Hall: “Happens Nowhere Else”
 Cancer Research Institute

CRI's Online Immunotherapy Patient Summit connects cancer patients and caregivers to scientific and medical experts, explores clinical trials, cancer care disparities

Comment
Released: 23-Aug-2021 12:30 PM EDT
Ana Patricia Gámez se une al Cancer Research Institute en su compromiso por la igualdad racial en el cuidado de la salud, como presentadora de la primera Conferencia Virtual en Español Sobre Inmunoterapia Contra el Cáncer
Cancer Research Institute

El Cancer Research Institute (CRI), organización sin fines de lucro liderando investigación revolucionaria sobre el poder de nuestro sistema inmunológico para controlar y potencialmente curar todos los tipos de cáncer, ofrecerá su primera Conferencia Virtual CRI de Inmunoterapia para Pacientes con Cáncer 2021 totalmente en español, el 16 de septiembre de 2021, de 2 a 5 p.m. (hora del este).

Comment
Released: 23-Aug-2021 12:05 PM EDT
Ana Patricia Gámez Joins Cancer Research Institute in the Movement for Racial Health Equity, Named Moderator of First Spanish-Language Virtual Cancer Immunotherapy Summit
Cancer Research Institute

The Cancer Research Institute (CRI), a nonprofit organization spearheading transformative research to harness the immune system’s power to control and potentially cure all cancers, will offer its first-ever Virtual Cancer Immunotherapy Summit in Spanish on September 16, 2021, 2-5 p.m. ET.

Comment
Released: 22-Jul-2021 8:00 AM EDT
Cancer Research Institute Awards $28.5 Million in Grants and Fellowships to Support Basic and Clinical Research in Immunology and Cancer Immunotherapy
 Cancer Research Institute

Cancer Research Institute announced grants and fellowships of $28.5 million to scientists advancing immunology and cancer immunotherapy research

Comment
Released: 22-Jul-2021 8:00 AM EDT
Cancer Research Institute Announces First Recipients of the New CRI Irvington Postdoctoral Fellowship to Promote Racial Diversity
Cancer Research Institute

Cancer Research Institute announces first recipients of new fellowship program designed to promote racial diversity and inclusion in immunology and tumor immunology

Comment
Released: 25-Jun-2021 8:00 AM EDT
El Cancer Research Institute Lanza Su Website Como Centro De InformacióN en EspañOl, en Su Compromiso De Liderar El Cambio Por La Igualdad Racial en El Cuidado De La Salud
Cancer Research Institute

El Cancer Research Institute anunció hoy que ha lanzado su primer website en español para conectar a los pacientes hispanos y sus cuidadores con la información más reciente sobre la inmunoterapia contra el cáncer y las opciones de tratamiento.

Comment
Released: 25-Jun-2021 8:00 AM EDT
Cancer Research Institute (CRI) Launches Spanish-Language Resource Hub in Its Commitment to Lead the Change in Racial Health Equity
Cancer Research Institute

The Cancer Research Institute (CRI) announced today that is has launched its first-ever Spanish-language information hub to connect Hispanic patients and caregivers with the latest cancer immunotherapy research and treatment options.

Comment
Released: 25-May-2021 7:00 PM EDT
Cancer Research Institute Celebrates Ninth Annual Cancer Immunotherapy Month™
 Cancer Research Institute

Cancer Research Institute celebrates progress in cancer immunotherapy research, announces new initiatives aimed at addressing racial and ethnic disparities in cancer treatment and academic research, during ninth annual Cancer Immunotherapy Month this June.

Comment
   
Released: 30-Mar-2021 7:00 AM EDT
Cancer Research Institute and RevImmune Announce Dosing of First Patient in New Phase 2 Study Assessing Therapeutic Benefit of Interleukin-7 in Patients with Cancer and COVID-19
 Cancer Research Institute and RevImmune

New immunotherapy approach to treating cancer patients with COVID-19 aims to reduce risk of severe COVID-19 symptoms by reinvigorating patients' cellular immune responses

Comment
Released: 11-Nov-2020 4:00 PM EST
Cancer Research Institute CEO and Director of Scientific Affairs Dr. Jill O’Donnell-Tormey Receives Inaugural Tara Withington Public Service Award from the Society for Immunotherapy of Cancer
 Cancer Research Institute

Award honors individuals and organizations that foster and enhance the field of cancer immunotherapy through increasing public understanding, awareness, research efforts, and/or funding

Comment
Released: 11-Nov-2020 11:35 AM EST
Combination Drug Strategies Gain Ground in Global Immuno-Oncology Pipeline of PD-1 and PD-L1 Clinical Trials, New Report from Cancer Research Institute Reveals
 Cancer Research Institute

Analysis update by the nonprofit Cancer Research Institute reveals dramatic growth in PD-1/PD-L1 monoclonal antibody combination cancer treatment strategies in global clinical trial pipeline

Comment
Released: 18-Sep-2020 8:30 AM EDT
Immunotherapy Drug Development Pipeline Continues Significant Growth in 2020 Despite Global Pandemic Impact
 Cancer Research Institute

Despite the impact of the COVID-19 pandemic across the globe, there has been a resurgence of interest in immuno-oncology (I-O) preclinical and clinical development, bringing hope to cancer patients and physicians who treat them.

Comment


close
0.1615